GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » Piotroski F-Score

Bioqual (Bioqual) Piotroski F-Score : 0 (As of Jun. 19, 2024)


View and export this data going back to . Start your Free Trial

What is Bioqual Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Bioqual has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Bioqual's Piotroski F-Score or its related term are showing as below:


Bioqual Piotroski F-Score Historical Data

The historical data trend for Bioqual's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual Piotroski F-Score Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 5.00 5.00 8.00 6.00

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 5.00 5.00 8.00 6.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (May18) TTM:Last Year (May17) TTM:
Net Income was $3.66 Mil.
Cash Flow from Operations was $3.71 Mil.
Revenue was $35.89 Mil.
Gross Profit was $8.73 Mil.
Average Total Assets from the begining of this year (May17)
to the end of this year (May18) was (22.76 + 26.305) / 2 = $24.5325 Mil.
Total Assets at the begining of this year (May17) was $22.76 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $20.25 Mil.
Total Current Liabilities was $3.46 Mil.
Net Income was $3.96 Mil.

Revenue was $36.60 Mil.
Gross Profit was $9.90 Mil.
Average Total Assets from the begining of last year (May11)
to the end of last year (May17) was (13.297 + 22.76) / 2 = $18.0285 Mil.
Total Assets at the begining of last year (May11) was $13.30 Mil.
Long-Term Debt & Capital Lease Obligation was $0.25 Mil.
Total Current Assets was $17.90 Mil.
Total Current Liabilities was $3.10 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Bioqual's current Net Income (TTM) was 3.66. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Bioqual's current Cash Flow from Operations (TTM) was 3.71. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (May17)
=3.662/22.76
=0.16089631

ROA (Last Year)=Net Income/Total Assets (May11)
=3.963/13.297
=0.29803715

Bioqual's return on assets of this year was 0.16089631. Bioqual's return on assets of last year was 0.29803715. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Bioqual's current Net Income (TTM) was 3.66. Bioqual's current Cash Flow from Operations (TTM) was 3.71. ==> 3.71 > 3.66 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: May18)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from May17 to May18
=0/24.5325
=0

Gearing (Last Year: May17)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from May11 to May17
=0.25/18.0285
=0.01386693

Bioqual's gearing of this year was 0. Bioqual's gearing of last year was 0.01386693. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: May18)=Total Current Assets/Total Current Liabilities
=20.253/3.464
=5.84670901

Current Ratio (Last Year: May17)=Total Current Assets/Total Current Liabilities
=17.901/3.1
=5.77451613

Bioqual's current ratio of this year was 5.84670901. Bioqual's current ratio of last year was 5.77451613. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Bioqual's number of shares in issue this year was 0.893. Bioqual's number of shares in issue last year was 0.893. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=8.725/35.885
=0.2431378

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=9.904/36.603
=0.27057891

Bioqual's gross margin of this year was 0.2431378. Bioqual's gross margin of last year was 0.27057891. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (May17)
=35.885/22.76
=1.5766696

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (May11)
=36.603/13.297
=2.75272618

Bioqual's asset turnover of this year was 1.5766696. Bioqual's asset turnover of last year was 2.75272618. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Bioqual has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Bioqual  (OTCPK:BIOQ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Bioqual Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Bioqual's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual (Bioqual) Business Description

Traded in Other Exchanges
N/A
Address
9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines